---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-002154"
form_type: "8-K"
ticker: "PMHS"
cik: "0001265521"
company_name: "Polomar Health Services, Inc."
filed_at: "2025-01-14T23:59:59+00:00"
generated_at: "2026-05-28T01:44:41.374503+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Polomar Health amends license with Pinata; adds pharmacy sub, sets royalties of 10-20%

## Summary
- Amended license covers metformin (10% royalty), semaglutide/liraglutide (20%), sumatriptan/sildenafil (15%).
- License is worldwide, non-exclusive, perpetual; may be terminated with 180 days notice or for uncured breach.
- Polomar Specialty Pharmacy, a wholly-owned Florida subsidiary, added as a licensee.
- Pinata is an affiliate of CWR 1 LLC, Polomar's majority shareholder (common ownership).

## SEC filing metadata
- accession: 0001493152-25-002154
- form_type: 8-K
- ticker: PMHS
- cik: 0001265521
- company_name: Polomar Health Services, Inc.
- filed_at: 2025-01-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1265521/000149315225002154/0001493152-25-002154-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1265521/000149315225002154/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-002154
- JSON: https://secwatch.observer/filing/0001493152-25-002154.json
- Plain text: https://secwatch.observer/filing/0001493152-25-002154.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.